FibroSURE&trade; and FibroScan&reg; in relation to treatment response in chronic hepatitis C virus

doi:10.3748/wjg.v17.i41.4581

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 41

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5157)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

516

HTML

4169

Figures (1-4)

255

Tables (1-2)

217

Sum=5157

Nov 7, 2011 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 7, 2011; 17(41): 4581-4589
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4581

Full Size Figure Download Figure

Figure 3 Changes in transient elastography with therapy according to sustained virological response. Mean FibroScan fibrosis scores over time by sustained virological response status in patients with hepatitis C virus (A) genotypes 2/3 and (B) genotype 1. FU: Follow-up.

Citation: Patel K, Friedrich-Rust M, Lurie Y, Grigorescu M, Stanciu C, Lee CM, Schiff ER, Häussinger D, Manns MP, Gerken G, Colle I, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG, Zeuzem S. FibroSURE^™ and FibroScan^® in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol 2011; 17(41): 4581-4589
URL: https://www.wjgnet.com/1007-9327/full/v17/i41/4581.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i41.4581